FGF23 and Obesity: To the best of our knowledge, this is the first study in children and adolescents with normal renal function that demonstrates the association of FGF-23, osteopontin, NGAL and sclerostin concentrations with obesity, cardiovascular risk factors and glucose homeostasis following a 1-year life-style intervention program.